Related Experiment Videos
Vancomycin-associated linear IgA dermatosis. A report of three cases
S Carpenter1, D Berg, N Sidhu-Malik
1Department of Medicine, Duke University Medical Center, Durham, NC 27710.
Journal of the American Academy of Dermatology
|January 1, 1992
Summary
Vancomycin can trigger linear IgA dermatosis, a rare blistering disease. This condition, characterized by IgA1 deposits, resolves upon drug cessation, mimicking idiopathic forms.
Area of Science:
- Dermatology
- Immunopathology
- Autoimmune Blistering Diseases
Background:
- Linear IgA dermatosis (LAD) is an autoimmune blistering disease.
- It is typically mediated by autoantibodies.
- Drug-induced cases are rare.
Observation:
- Three patients developed subepidermal blistering disease after vancomycin administration.
- The condition resolved after discontinuing vancomycin.
- This suggests a causal link between vancomycin and LAD.
Findings:
- Immunofluorescence revealed linear IgA1 deposits at the sublamina densa.
- No circulating IgA anti-basement membrane zone antibodies were detected.
- The immunopathology mirrors idiopathic LAD.
Implications:
- Vancomycin should be considered a potential cause of linear IgA dermatosis.
- Understanding the immunopathology aids in diagnosis and management.
- This finding expands the differential diagnosis for drug-induced skin reactions.